Charles River Laboratories CRL Net Income (NCI)
Net Income (NCI) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLossAttributableToNoncontrollingInterest.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's net income (nci).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's net income (NCI)?
- Charles River Laboratories (CRL) reported net income (NCI) of $41K in Q1 2026.
- How has Charles River Laboratories's net income (NCI) changed year-over-year?
- Charles River Laboratories's net income (NCI) decreased by 90.0% year-over-year, from $409K to $41K.
- What is the long-term trend for Charles River Laboratories's net income (NCI)?
- Over 2 years (2023 to 2025), Charles River Laboratories's net income (NCI) has grown at a -38.5% compound annual growth rate (CAGR), from $5.75M to $2.18M.
- What does net income (NCI) mean?
- The share of profits belonging to outside owners of the company's subsidiaries.
- How do you interpret net income (NCI)?
- An increase suggests that the company's partially-owned subsidiaries are becoming more profitable, which reduces the net income available to the parent company's shareholders.
- How does net income (NCI) compare across companies?
- Common for companies with complex corporate structures or joint ventures.